Nur ARSLAN, Fatih DEMİRCİOĞLU, Handan ÇAKMAKÇI, Sedat TUNCEL, Benal BÜYÜKGEBİZ, Şamil HIZLI, Ali KOÇYİĞİT

The role of ultrasonographic hepatic artery resistive index in the diagnosis of insulin resistance in obese children with non-alcoholic fatty liver disease

To determine the role of hepatic artery resistive index (HARI) measurement in the prediction of insulin resistance (IR) in obese children with nonalcoholic fatty liver disease (NAFLD). Materials and methods: A total of 64 obese subjects with NAFLD (13.5 ± 1.36 years of age, 34 male) and 32 age- and gender-matched control subjects (13.8 ± 1.24 years of age, 16 male) were enrolled in the study. All subjects underwent a physical examination, laboratory tests, and ultrasonographic and Doppler examinations of the liver. The homeostasis model assessment of IR (HOMA-IR) was used for the IR diagnosis. Results: Obese subjects with NAFLD had significantly higher HARI, insulin, alanine aminotransferase (ALT), total cholesterol (TC), triglycerides (TG), and HOMA-IR than the control subjects. Obese subjects with NAFLD and IR had significantly higher HARI compared to obese subjects with NAFLD but without IR (0.761 ± 0.04 vs. 0.732 ± 0.04, P = 0.006). Changes in HARI correlated significantly to changes in BMI, SDS-BMI, MAC, TSF, MAC, ALT, TC, insulin, and HOMA-IR (r = 0.578, P = 0.001; r = 0.547, P = 0.001; r = 0.549, P = 0.001; r = 0.504, P = 0.001; r = 0.549, P = 0.001; r = 0.223, P = 0.029; r = 0.306, P = 0.002; r = 0.315, P = 0.011; r = 0.295, P = 0.018, respectively). As an optimal cutoff point, a HARI level of 0.715 determined IR with 81.2% sensitivity and 71.9% specificity. Conclusion: Our findings suggest that HARI might be used as a simple and non-invasive screening method to predict IR in obese children with NAFLD.

Anahtar Kelimeler:

Key words: Obesity, insulin resistance, nonalcoholic fatty liver disease, hepatic artery resistive index, adolescent, Doppler ultrasonography

The role of ultrasonographic hepatic artery resistive index in the diagnosis of insulin resistance in obese children with non-alcoholic fatty liver disease

Keywords:

Key words: Obesity, insulin resistance, nonalcoholic fatty liver disease, hepatic artery resistive index, adolescent, Doppler ultrasonography,

PDF

___

Wanless IR, Lentz JS. Fatty liver hepatitis (steatohepatitis) and obesity an autopsy analysis of risk factors. Hepatology 1990; 12: 1106-10.
Joy D, Thava VR, Scott BB. Diagnosis of fatty liver disease: is biopsy necessary? Eur J Gastroenterol Hepatol 2003; 15: 539- 43.
Pierce ME, Sewell R. Identification of hepatic cirrhosis by duplex doppler ultrasound value of the hepatic artery resistive index. Australas Radiol 1990; 34: 331-3.
Saverymuttu SH, Joseph AE, Maxwell JD. Ultrasound scanning in the detection of hepatic fibrosis and steatosis. Br Med J 1986; 292: 13-5.
Arslan N, Büyükgebiz B, Öztürk Y, Cakmakci H. Fatty liver in obese children: prevalence and correlation with anthropometric measurements and hyperlipidemia. Turk J Pediatr 2005; 47: 23- 7.
Sacerdoti D, Merkel C, Bolognesi M, Amodio P, Angeli P, Gatta A. Hepatic arterial resistance in cirrhosis with and without portal vein thrombosis: relationships with portal hemodynamics. Gastroenterology 1995; 108: 1152-8.
Colli A, Cocciolo M, Mumoli N, Cattalini N, Fraquelli M, Conte D. Hepatic artery resistance in alcoholic liver disease. Hepatology 1998; 28: 1182-6.
Tanaka K, Numata K, Morimoto M, Shirato K, Kokawa A, Tomita N et al. Elevated resistive index in the hepatic artery as a predictor of fulminant hepatic failure in patients with acute viral hepatitis: a prospective study using Doppler ultrasound. Dig Dis and Science 2004; 49: 833-42.
Broide E, Farrant P, Reid F, Baker A, Meire H, Rela M et al. Hepatic artery resistance index can predict early death in children with biliary atresia. Liver Transpl Surg 1997; 3: 604-10.
de Onis M, Onyango AW, Borghi E, Siyam A, Nishida C, Siekmann J. Development of a WHO growth reference for school-aged children and adolescents. Bull World Health Organ. 2007; 85: 660-7.
http://www.who.int/growthref/en/
Valerio G, Licenziati MR, Iannuzzi A, Franzese A, Siani P, Riccardi G et al. Insulin resistance and impaired glucose tolerance in obese children and adolescents from Southern Italy. Nutr Metab Cardiovasc Dis 2006; 16: 279-284.
de Jongh RT, Serné EH, IJzerman RG, Jİrstad HT, Stehouwer CD. Impaired local microvascular vasodilatory effects of insulin and reduced skin microvascular vasomotion in obese women. Microvasc Res 2008; 75: 256-62.
Nacci C, Tarquinio M, Montagnani M. Molecular and clinical aspects of endothelial dysfunction in diabetes. Intern Emerg Med 2009; 4: 107-16.
Bourgoin F, Bachelard H, Badeau M, Melançon S, Pitre M, Lariviere R et al. Endothelial and vascular dysfunctions and insulin resistance in rats fed a high-fat, high-sucrose diet. Am J Physiol Heart Circ Physiol 2008; 295: H1044-H1055.
Nadeau KJ, Ehlers LB, Zeitler PS, Love-Osborne K. Treatment of non-alcoholic fatty liver disease with metformin versus lifestyle intervention in insulin-resistant adolescents. Pediatr Diabetes 2009; 10: 5-13.
Schwimmer JB, Milddleton MS, Deutsch R, Lavine JE. A phase 2 clinical trial of metformin as a treatment for non-diabetic paediatric non-alcoholic steatohepatitis. Aliment Pharmacol Ther 2005; 21: 871-879.
Karabulut N, Kazil S, Yagci B, Sabir N. Doppler waveform of the hepatic veins in an obese population. Eur Radiol. 2004; 14: 2268-72.